Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019

Abstract

BackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Disease Study (GBD) 2019 and assessed the mortality, age-standardized death rate (ASDR), and population attributable fractions (PAFs) of cancers attributable to metabolic factors. Average annual percentage changes (AAPCs) were calculated to assess the changes in the ASDR. The cancer mortality burden was evaluated according to geographic location, SDI quintiles, age, sex, and changes over time.ResultsCancer attributable to metabolic factors contributed 865,440 (95% UI, 447,970-140,590) deaths in 2019, a 167.45% increase over 1990. In the past 30 years, the increase in the number of deaths and ASDR in lower SDI regions have been significantly higher than in higher SDI regions (from high to low SDIs: the changes in death numbers were 108.72%, 135.7%, 288.26%, 375.34%, and 288.26%, and the AAPCs were 0.42%, 0.58%, 1.51%, 2.36%, and 1.96%). Equatorial Guinea (AAPC= 5.71%), Cabo Verde (AAPC=4.54%), and Lesotho (AAPC=4.42%) had the largest increase in ASDR. Large differences were observed in the ASDRs by sex across different SDIs, and the male-to-female ratios of ASDR were 1.42, 1.50, 1.32, 0.93, and 0.86 in 2019. The core population of death in higher SDI regions is the age group of 70 years and above, and the lower SDI regions are concentrated in the age group of 50-69 years. The proportion of premature deaths in lower SDI regions is significantly higher than that in higher SDI regions (from high to low SDIs: 2%, 4%, 7%, 7%, and 9%). Gastrointestinal cancers were the core burden, accounting for 50.11% of cancer deaths attributable to metabolic factors, among which the top three cancers were tracheal, bronchus, and lung cancer, followed by colon and rectum cancer and breast cancer.ConclusionsThe cancer mortality burden attributable to metabolic factors is shifting from higher SDI regions to lower SDI regions. Sex differences show regional heterogeneity, with men having a significantly higher burden than women in higher SDI regions but the opposite is observed in lower SDI regions. Lower SDI regions have a heavier premature death burden. Gastrointestinal cancers are the core of the burden of cancer attributable to metabolic factors.

Trends in breast cancer mortality attributable to metabolic risks in Chinese women from 1990 to 2019: an age-period-cohort analysis

“…Risk factors associated with BC were well documented including physiological conditions, family history, metabolic risk, lifestyle factors, etc ( 5 ). In recent years, metabolic risks (MRs) have shown a growing influence on cancer-related deaths worldwide ( 6 , 7 ) due to rapid economic and social development which has brought dramatic changes in the dietary structure and behavior of the population ( 8 , 9 ). China is also facing a significant burden of diseases linked to MRs among G20 nations ( 10 ), particularly in individuals over 60 years old.…”

“…Elevated MRs are reported to be closely correlated with heightened BC mortality risk. Over the last three decades, BC mortality attributed to MRs has surpassed behavioral risks, emerging as the leading risk factor for BC in Chinese women ( 6 , 11 , 12 ).…”

Elucidation of interleukin-19 as a therapeutic target for breast cancer by computational analysis and experimental validation

“…Over the following two decades, the burden of cancer will rise by around 60%, placing additional strain on healthcare systems, individuals, and communities. By 2040, it is anticipated that there will be roughly 30 million additional instances of cancer worldwide, with the largest increases occurring in low- and middle-income nations ( Zhang et al, 2023 ). Worldwide it remains a major health concern ( Correia et al, 2021 , Mir et al, 2022 ).…”

Attitudes and perceptions of cancer patients and healthcare providers towards prehabilitation: A thematic synthesis

“…Cancer is a global disease that causes significant physical and psychological burden to patients and their families (Zhang et al., 2023). According to GLOBOCAN 2020, there are an estimated 19.3 million new cases of cancer globally, and it is the first or second leading cause of death before the age of 70 in most countries (Sung et al., 2021).…”